In 2022, Dr. Claus Møller earned $1.21M in total compensation at Y-mAbs Therapeutics, Inc., primarily from $283.04K salary. Most recently sold 50,000 shares in Dec 2020. Currently holds stock worth $16.36K. Led Y-mAbs Therapeutics, Inc. as CEO for 6 years.
Compensation History
Annual executive compensation data for Dr. Claus Møller, including salary, bonuses, and stock awards.
Year
2022
Total Compensation
$1.21M
Salary
$283.04K
Bonus
$0.00
Other
$924.54K
Salary
$283.04KBoard Justification
The compensation philosophy aims to attract and retain top executive talent while aligning compensation with company performance and market benchmarks.
Bonus
$0.00Board Justification
Dr. Møller did not receive a performance-based cash bonus for 2022 given his departure in April 2022.
Other Compensation
$924.54KBoard Justification
Includes severance payments and benefits, a monthly housing allowance, telephone expenses, and accident insurance premiums.
Restricted Stock
Board Justification
No stock was vested in 2022 as Dr. Møller's existing equity awards which have been granted but not vested as of the Effective Date will vest in accordance with the standard vesting schedule consistent with a termination without cause.
Performance Metrics
Performance metrics for the CEO's compensation were not applicable for 2022 due to his departure.
Dr. Claus Møller
Ex-CEO of Y-mAbs Therapeutics, Inc.
Education
Ph.D. in Pharmaceutical Sciences from the University of Copenhagen
Sector of Economy
Healthcare
Born
January 1, 1971 - 54 years ago
CEO of Y-mAbs Therapeutics, Inc. for
6 years 1 month (Mar 2016 - Apr 2022)
Previous Experience
Formerly held positions at various pharmaceutical companies including Novo Nordisk and Amgen.
Other Y-mAbs Therapeutics, Inc. CEOs
Holdings
Track Dr. Claus Møller's stock holdings and portfolio value over time.
Total Stock Sold
$9.87M
$9.87M
250,000 YMAB shares
What if they kept their stock?
If Dr. Claus Møller didn't sell their stock, today they would have:
Extra YMAB250,000 shares worth $2.15M.
This is -78.18% and $7.71M less than what they got when they sold the stock.
Insider Trading
Dr. Claus Møller's recent stock transactions, purchases, and sales filed with the SEC.
$2.56M
YMAB at $51.12/share
Dec 2, 2020
Sale
$7.38M
YMAB at $36.89/share
May 13, 2020
Sale
$32.71K
YMAB at $17.22/share
Mar 17, 2020
Purchase
Rivals
Compare Dr. Claus Møller with competitor CEOs and industry peers.